The search for broad-spectrum antiviral compounds is a continuous mandatory effort. The recent approval of the first -nucleoside carrying a nitrile as a substituent at the C1' position of the ribose ring has raised interest in this underexplored substitution pattern. We have previously reported the development of different 1,2,3-triazolyl--ribonucleosides with anticancer and antiviral activities. Herein we report our results on the incorporation of a C1'-CN group in 1,2,3-triazolyl--ribonucleosides.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d2ob01403c | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!